Skip to content

Clinical trials

Myocardial Infarction trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: Italy Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20034
20042
20054
20067
20074
20084
20092
20108
201110
20124
201310
20143
20153
20164
20172
20183
20195
20206
20215
20224
20237
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Unknown status27
Recruiting11
Terminated11
Active, not recruiting9
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Federico II University4
Novartis Pharmaceuticals4
Amaranth Medical Inc.3
Azienda Ospedaliero Universitaria Maggiore della Carita3
Boehringer Ingelheim3
Catholic University of the Sacred Heart3
Fondazione IRCCS Policlinico San Matteo di Pavia3
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III3
University Hospital of Ferrara3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction117
Acute Coronary Syndrome23
Coronary Artery Disease19
Cardiovascular Diseases17
Stroke17
ST Elevation Myocardial Infarction14
Non-ST Elevated Myocardial Infarction12
Heart Diseases11
Myocardial Ischemia11
Angina, Unstable9

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.